Item 5. OTHER INFORMATION

On May 3, 2024, Ms. Deborah Marson, our Executive Vice President, General Counsel and Secretary, adopted a 10b5-1 trading plan to exercise options to purchase up to 4,636 shares of our common stock and sell up to 29,836 shares of our common stock between August 9, 2024 and March 31, 2025. Ms. Marson’s plan will terminate on the earlier of (i) March 31, 2025 and (ii) the date that all trades under the plan are completed.

On June 12, 2024, Mr. Walter Rakowich, a member of our board of directors, adopted a 10b5-1 trading plan to sell up to 40% of the gross shares to be acquired upon vesting of his 2025 and 2026 annual equity awards between May 28, 2025 and June 30, 2026. Mr. Rakowich’s plan will terminate on the earlier of (i) June 30, 2026 and (ii) the date that all trades under the plan are completed.

Each of these arrangements was entered into during an open trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934.